LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.42B | 1.37B | 1.32B | 1.28B | 1.25B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.42B | 1.37B | 1.32B | 1.28B | 1.25B |
| Cost of Revenue | 963.19M | 923.33M | 888.39M | 866.04M | 848.57M |
| Gross Profit | 461.10M | 444.24M | 428.09M | 417.46M | 402.40M |
| SG&A Expenses | 382.24M | 380.55M | 369.77M | 367.14M | 360.90M |
| Depreciation & Amortization | 54.75M | 55.99M | 57.55M | 62.14M | 70.95M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.40B | 1.36B | 1.32B | 1.30B | 1.28B |
| Operating Income | 24.11M | 7.70M | 769.00K | -11.82M | -29.45M |
| Income Before Tax | 12.36M | -11.72M | -21.67M | -38.35M | -57.61M |
| Income Tax Expenses | 2.70M | -2.60M | -5.52M | -2.71M | -170.00K |
| Earnings from Continuing Operations | 9.66 | -9.12 | -16.15 | -35.64 | -57.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.66M | -9.12M | -16.15M | -35.64M | -57.44M |
| EBIT | 24.11M | 7.70M | 769.00K | -11.82M | -29.45M |
| EBITDA | 78.86M | 63.69M | 58.32M | 50.32M | 41.50M |
| EPS Basic | 0.02 | -0.02 | -0.04 | -0.09 | -0.15 |
| Normalized Basic EPS | 0.02 | -0.02 | -0.03 | -0.06 | -0.09 |
| EPS Diluted | 0.02 | -0.03 | -0.05 | -0.10 | -0.16 |
| Normalized Diluted EPS | 0.02 | -0.02 | -0.03 | -0.06 | -0.09 |
| Average Basic Shares Outstanding | 1.54B | 1.54B | 1.53B | 1.52B | 1.52B |
| Average Diluted Shares Outstanding | 1.56B | 1.55B | 1.54B | 1.53B | 1.52B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |